韦氏环恶性淋巴瘤不同放化疗疗效分析
被引量:3
An Analysis of the Treatment Efficacy of Different Radiotherapy and Chemotherapy Methods in Patients with Malignant Lymphoma of Waldeyer's Ring
摘要
对107例Ⅰ、Ⅱ期韦氏环恶性淋巴瘤治疗情况分析 ,放化疗联合治疗5年生存率明显优于单纯放疗或单纯化疗 ,以3个周期以上化疗后放疗为最佳。
出处
《肿瘤学杂志》
CAS
2002年第6期360-361,共2页
Journal of Chinese Oncology
参考文献4
-
1顾仲义,顾本惠,姚玉珍,孟婉珍,黄克伟,朱向帜.Ⅱ期咽淋巴环非霍奇金淋巴瘤治疗探讨[J].中华放射肿瘤学杂志,1998,7(3):138-141. 被引量:12
-
2Ezzat AA,Ibrahim EM.Localized non_Hodgkin's lymphoma of Waldeyer's ring:clinical features,management,and prognosis of 130 adul patients[J].Head Neck,2001,23(7):547- 558.
-
3Miller CM,Dahlberg S,Cassady JR,et al.Chemotherapy alone compary with chemotherapy plus radiotherapy for localized intermediate and high grade non Hodgkin's lymphoma[J]. New Eng J Med,1998,339:21- 26.
-
4Kobayashi Y,Oging T.Prognostic factors in non_Hodgkin's lymphoma of Waldeyer's ring and the lymph nodes of the neck[J].Nippon Jibiinkoka Gakkai Kaiho,2000,103(6):761- 768.
二级参考文献12
-
1Fisher RI,Gaynor ER,Dahlberg S,et al.Comparison of a standard regimen(CHOP)with three intensive chemotherapy regiments for advanced non Hodgkin's lymphoma.N Engl J,1993,328:1002-1006.
-
2Banfi A,Bonadona G,Ricci SB,et al.Malignant lymphoma of Waldeyer's ring,Natural history and survival after radiotherapy.Br Med J,1972,3:140-143.
-
3Econompoulos T,Asprou N,Stathakis N,et al.Primary extranodal non-Hodgkins's lymphoma of the head and neck.Oncol,1992,49:484-488.
-
4Kondo M,Mikata A,Ogawa K,et al.Prognostic factors in stage I and II non-Hodgkin's lymphoma of Waldeyer's ring.Acra Radiol Oncol,1985,24:153-165.
-
5李靖 黄一容 顾大中.原发于咽琳巴环的非何杰金氏淋巴瘤—103例预后分析[J].中华放射肿瘤学杂志,1992,1:24-27.
-
6陈明鸣 王捷忠 林祥松.I、Ⅱ期咽淋巴环非何杰金氏淋巴瘤疗效分析[J].中华放射肿瘤学杂志,1995,4:97-97.
-
7顾仲义 顾奉惠 钱婉.I、Ⅱ期咽淋巴环非何杰金氏淋巴瘤—183例预后分析[J].中国放射肿瘤学杂志,1987,1:6-8.
-
8Stahel RA,Jost LM,Pichert G,et al.High dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas.Cancer Treatment Reviews,1995,21:3-32.
-
9Arriagada R,Cosset JM,Chevalier J,et al.The value of adjunctive radiotherapy when chemotherapy is the major curative method.Int J Radiat Oncol Biol Phys,1990,19:1279-1284.
-
10Uematsu N Kondo M,Hiramatsu H,et al.Stage IA non-Hodgkin's lymphoma of the Waldeyer's limited chemotherapy and radiotherapy versus radiotherapy alone.Acta Oncol,1993,32:675-678.
共引文献11
-
1聂大红,谢方云,胡伟汉,伍勇,张述平.韦氏环非霍奇金淋巴瘤化疗及放疗的选择[J].中国肿瘤临床,2004,31(14):827-828.
-
2袁智勇,李晔雄,赵路军,高远红,刘新帆,顾大中,钱图南,余子豪.鼻咽非霍奇金淋巴瘤的临床与预后分析[J].中华肿瘤杂志,2004,26(7):425-429. 被引量:16
-
3陈森,李明,刘少兵,周祖金.Ⅱ期咽淋巴环非霍奇金淋巴瘤36例[J].肿瘤研究与临床,2007,19(9):621-622. 被引量:1
-
4皮正超,李长青.鼻咽非霍奇金淋巴瘤的放射治疗[J].肿瘤研究与临床,1999,11(3):196-197.
-
5郭蕊,钱立庭,张红雁,刘云琴,李广虎,朱大高,陶振超.韦氏环非霍奇金淋巴瘤综合治疗疗效及其预后因素分析[J].中华肿瘤防治杂志,2012,19(10):780-782. 被引量:3
-
6王绿化,王维虎,黄一容,余子豪,刘新帆,周立强.Ⅰ期非霍奇金淋巴瘤的治疗及预后分析[J].中华放射肿瘤学杂志,2000,9(1):14-16. 被引量:7
-
7陈述嫦.原发于淋巴结外非霍奇金氏淋巴瘤53例分析[J].实用癌症杂志,2000,15(5):530-532.
-
8钟久鸿,邓建林,陈声波.非何杰金氏淋巴瘤临床特点及化疗近期疗效分析[J].江西医学院学报,2001,41(1):103-104. 被引量:1
-
9符红普.咽淋巴环淋巴瘤治疗方法及其预后因素的分析[J].白血病.淋巴瘤,2002,11(2):106-108. 被引量:2
-
10李晔雄,高远红,袁智勇,赵路军,刘新帆,余子豪.国际预后指数在韦氏环非霍奇金淋巴瘤的预后意义[J].中华放射肿瘤学杂志,2002,11(2):105-110. 被引量:34
同被引文献41
-
1秦燕,石远凯,何小慧,杨建良,杨晟,于燕霞,李博,王奇璐,周立强,孙燕.原发扁桃体非霍奇金淋巴瘤89例临床分析[J].癌症,2006,25(4):481-485. 被引量:9
-
2励菁菁,胡钧培.咽淋巴环非霍奇金淋巴瘤101例临床及预后分析[J].临床血液学杂志,2007,20(2):78-80. 被引量:1
-
3孙燕.肿瘤内科手册[M].北京:人民卫生出版社,2009:5.194.
-
4Yong WB, Zhang YT, Zheng W, et al. Prognostic factors and therapeutic efficacy of combined radio chemotherapy in Wa|dey ers ring non-Hodgkin s lymphoma ]. Chinese Med J, 2004, 113(2) : 148-150.
-
5Daniel T,Chang MD, Nancy P, et al. Long-term outcomes for stage I 11 aggressive non-Hodgkin's lymphoma of waldeyer's ring. O- riginal Article,2009,32(3) :232-237.
-
6JacobsC,HoopeRT. Non Hodgkin'slymphomaof the head and neck extranodal sites[J. Int J Radiat Oneol Biol Phys, 1985,11 (2) :357-364.
-
7Laskar S, Mohindra P, Gupta S, et al. Non-Hodgkins [ymphoma of Waldeyer's Ring:clinicopathologic and therapeutic issues. Leuk Lymphorna,2008,49(12) :2263 2271.
-
8Roh JL,Huh J,Moon HN. Lymphomas of the head neck in the pediatric population. Int J Pediatr Otorhinolaryngol, 2007,71 (9) :1471-1477.
-
9Shipp MA, Harnngton DP, Anderson JR, et ah A predictive mod el for aggressive non Hodgkin's lymphorna. N Eng J Med, 1993,329(14) =987-994.
-
10Bahl G,Laskar S,Muckaden MA,et al.Non-Hodgkin lymphoma of the Waldeyer's ring:.Is a higher radiotherapy dose required?[J].J Clin Oncol,2007,25:8067.
引证文献3
-
1郭蕊,钱立庭,张红雁,刘云琴,李广虎,朱大高,陶振超.韦氏环非霍奇金淋巴瘤综合治疗疗效及其预后因素分析[J].中华肿瘤防治杂志,2012,19(10):780-782. 被引量:3
-
2宋扬,黄韵红,胡云飞,刘小梅.韦氏环非霍奇金淋巴瘤化疗后序贯放射治疗的回顾性临床研究[J].白血病.淋巴瘤,2014,23(12):751-753. 被引量:3
-
3宋腾,梁绍平,李静敏,陈海珠,李书苹,王华庆.123例原发韦氏环弥漫大B细胞淋巴瘤临床特征与预后分析[J].肿瘤防治研究,2016,43(5):382-386. 被引量:1
二级引证文献7
-
1郭涛.吡柔比星辅助化疗方案治疗老年人恶性淋巴瘤的疗效观察[J].国际医药卫生导报,2015,21(20):2980-2982. 被引量:3
-
2张海亮,兰胜民,曹建忠,王宏卫,张宁,于剑飞,任淑惠,鲁萍.咽淋巴环弥漫大B细胞淋巴瘤66例临床特征及预后分析[J].肿瘤研究与临床,2015,27(12):816-819. 被引量:1
-
3宋腾,梁绍平,李静敏,陈海珠,李书苹,王华庆.123例原发韦氏环弥漫大B细胞淋巴瘤临床特征与预后分析[J].肿瘤防治研究,2016,43(5):382-386. 被引量:1
-
4李春艳,郭晔.原发韦氏环非霍奇金淋巴瘤的临床特点及治疗现状[J].中国癌症杂志,2018,28(4):315-320. 被引量:3
-
5杨明,冯彦林,冼伟均,鲁胜男,王颖,李雯,黄克敏.应用18F-FDG PET/CT评估不同CD5表达的弥漫大B细胞淋巴瘤化疗疗效及价值[J].肿瘤防治研究,2019,46(10):926-931. 被引量:3
-
6戴玉辉,李冬,邓萍萍,樊亮.韦氏环非霍奇金淋巴瘤1例并文献复习[J].中国医学文摘(耳鼻咽喉科学),2020,35(3):212-213.
-
7马肖容,徐燕,王瑾,张王刚,陈银霞,曹星梅,何爱丽,刘捷,王剑利,赵万红,杨云.254例非霍奇金淋巴瘤的临床疗效与预后分析[J].中国实验血液学杂志,2016,24(4):1044-1050. 被引量:18
-
1吴燕子,李彩萍.鼻、咽部恶性淋巴瘤诊断探讨[J].农垦医学,2001,23(3):172-173. 被引量:1
-
2岂连鹏,高玉环.足叶乙甙在恶性淋巴瘤治疗中的应用[J].中华血液学杂志,1993,14(6):316-317.
-
3肖卫国.恶性淋巴瘤治疗中的耐药机制[J].日本医学介绍,1995,16(7):306-307.
-
4李业楠(综述),邱录贵(审校).氟达拉滨在侵袭性淋巴瘤中的应用[J].国际输血及血液学杂志,2007,30(1):83-86.
-
5伍钢.放射治疗在恶性淋巴瘤治疗中的地位[J].中华肿瘤防治杂志,2009,16(16):1201-1205. 被引量:5
-
6孙健冰,林丽,刘莲卿.CIK细胞免疫治疗恶性淋巴瘤31例护理[J].福建医药杂志,2010,32(3):146-147. 被引量:8
-
7黎佳全,杨权烈,李亮,郭维新,邹浩元,黄国栋.韦氏环、鼻腔恶性淋巴瘤25例临床分析[J].陕西肿瘤医学,2001,9(1):30-30. 被引量:2
-
8王柏勋.G-CSF在恶性淋巴瘤治疗中的作用[J].日本医学介绍,1995,16(7):295-295.
-
9郭姗琦,赵海丰,张翼鷟.恶性淋巴瘤的表观遗传调控与治疗[J].中华肿瘤杂志,2014,36(3):161-164. 被引量:6
-
10黄非,朱彦,杨苏南,罗鸣,朱晓霞.粒系集落刺激因子在恶性淋巴瘤治疗中的作用[J].镇江医学院学报,1999,9(2):179-181.